XPO1 inhibitor (SINE compound) combined with corticosteroid
This page covers all XPO1 inhibitor (SINE compound) combined with corticosteroid drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting XPO1 (Exportin-1).
Targets
Phase 3 pipeline (1)
- Selinexol and Dexamethasone · Beijing Friendship Hospital · Oncology
Selinexol inhibits nuclear export of tumor suppressor proteins by blocking XPO1, while dexamethasone provides immunosuppressive and anti-inflammatory effects to enhance tolerability.
Patent intelligence
- xpo1 inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates